MYELODYSPLASTIC SYNDROME WITH ISOLATED DEL(5Q)

Clinical trials for MYELODYSPLASTIC SYNDROME WITH ISOLATED DEL(5Q) explained in plain language.

Never miss a new study

Get alerted when new MYELODYSPLASTIC SYNDROME WITH ISOLATED DEL(5Q) trials appear

Sign up with your email to follow new studies for MYELODYSPLASTIC SYNDROME WITH ISOLATED DEL(5Q), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

New drug duo targets Tough-to-Treat leukemia

Disease control Completed

This study tested whether combining two drugs, sirolimus and azacitidine, could help control high-risk myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML) in adults. The trial enrolled 57 patients whose cancer had returned or who could not tolerate standard high-dose c…

Matched conditions: MYELODYSPLASTIC SYNDROME WITH ISOLATED DEL(5Q)

Phase: PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University • Aim: Disease control

Last updated Apr 01, 2026 14:41 UTC

MYELODYSPLASTIC SYNDROME WITH ISOLATED DEL(5Q)

Get alerted when new MYELODYSPLASTIC SYNDROME WITH ISOLATED DEL(5Q) trials appear

New drug duo targets Tough-to-Treat leukemia